EGFR and glioblastoma: Hadjipanayis et al. reported a study in which magnetic NPs conjugated to an EGFR deletion mutant (EGFRvIII) antibody are used for GBM detection (via magnetic resonance imaging (MRI)) and targeted therapy [47] (see also Table 1).